The relationship between post‐traumatic stress and post‐traumatic growth in cancer patients and survivors: A systematic review and meta‐analysis

Marziliano, Allison; Tuman, Malwina; Moyer, Anne

doi:10.1002/pon.5314

Cited by 124 publications

(115 citation statements)

References 66 publications

Supporting

Mentioning

103

Contrasting

Unclassified

Order By: Relevance

“…In terms of the regression analysis, shorter time since the cancer diagnosis, higher levels of general stress (i.e., higher PSS scores), and the occurrence of pain were significant predictors of membership in the stressed group. Although in a recent systematic review, 78 no association was found between time since cancer diagnosis and PTSD, this nonmodifiable characteristic may be used to identify high-risk patients. It is interesting to note that patients with higher scores on our measure of general stress were more likely to be in the stressed group.…”

Section: Discussionmentioning

confidence: 89%

Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic

Miaskowski

Paul

Snowberg

et al. 2020

Journal of Pain and Symptom Management

113

123

View full text Add to dashboard Cite

Context. No information is available on oncology patients' level of stress and symptom burden during the coronavirus disease 2019 (COVID-19) pandemic. Objectives. To evaluate for differences in demographic and clinical characteristics, levels of social isolation and loneliness, and the occurrence and severity of common symptoms between oncology patients with low vs. high levels of COVID-19 and cancer-related stress. In addition, to determine which of these characteristics were associated with membership in the highstressed group. Methods. Patients were 18 years and older; had a diagnosis of cancer; and were able to complete an online survey. Results. Of the 187 patients in this study, 31.6% were categorized in the stressed group (Impact of Event ScaledRevised [score of $24]). Stressed group's Impact of Event ScaledRevised score exceeds previous benchmarks in oncology patients and equates with probable post-traumatic stress disorder. In this stressed group, patients reported occurrence rates for depression (71.2%), anxiety (78.0%), sleep disturbance (78.0%), evening fatigue (55.9%), cognitive impairment (91.5%), and pain (75.9%). Symptom severity scores equate with clinically meaningful levels for each symptom. Conclusion. We identified alarmingly high rates of stress and an extraordinarily high symptom burden among patients with cancer, exceeding those previously benchmarked in this population and on par with noncancer patients with post-traumatic stress disorder. Given that the COVID-19 pandemic will likely impact cancer care for an indefinite period, clinicians must exhibit increased vigilance in their assessments of patients' level of stress and symptom burden. Moreover, an increase in referrals to appropriate supportive care resources must be prioritized for high-risk patients. J Pain Symptom Manage 2020;60:e25ee34.

show abstract

Section: Discussionmentioning

confidence: 89%

Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic

Miaskowski

Paul

Snowberg

et al. 2020

Journal of Pain and Symptom Management

113

123

View full text Add to dashboard Cite

show abstract

“…Moreover, metaanalyses investigating whether the results were moderated by measures assessing BF vs. PTG did not find an effect, suggesting that associations are largely comparable for BF and PTG. This metaanalytic evidence revealed as well that BF and PTG showed a small positive association with posttraumatic stress [5,7]. Furthermore, small associations were reported for enhanced positive well-being, while the association between BF or PTG and negative mental health as well as subjective physical health remains inconclusive [1,3].…”

Section: Introductionmentioning

confidence: 81%

Benefit finding in long-term prostate cancer survivors

Lassmann

Dinkel

Marten‐Mittag

et al. 2021

Support Care Cancer

View full text Add to dashboard Cite

Purpose Benefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors. Methods BF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis. Results Mean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF. Conclusions BF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors. Implications for cancer survivors PCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative.

show abstract

“…9,10 Among those who have experienced traumatic events, the PTG of cancer patients has always been the focus of interest. 11,12 The factors of their PTG mainly relate to social support, the time and degree of illness, and coping style. [12][13][14] There has been little recent progress in identifying the influencing factors of PTG among people who fight against major infectious diseases, especially medical workers.…”

Section: Introductionmentioning

confidence: 99%

The Traumatic Experience of Clinical Nurses During the COVID-19 Pandemic: Which Factors are Related to Post-Traumatic Growth?

Zhang

Shi

Ren

et al. 2021

RMHP

View full text Add to dashboard Cite

Post-traumatic growth (PTG) is a positive result of fighting against traumatic events. This study aimed to investigate the current status of PTG of clinical nurses and analyze its influencing factors. Methods: A total of 1790 nurses participated in the study and completed the questionnaire. Demographic data and related scales of PTG, post-traumatic stress disorder, coping style, social support, and self-efficacy were collected online. Through univariate analysis and multiple linear regression analysis, the related influencing factors were studied. Results: The total score of PTG of 1790 nurses was 67.17 ± 14.79. The analysis revealed that good social support and self-efficacy were important factors to improve the level of PTG of clinical nurses, while bad psychological state and working for many years were the negative factors of PTG. Conclusion: Good social support and self-efficacy can help clinical nurses cope with the novel coronavirus disease 2019 pandemic and accept the disease's challenges. If these factors can be considered in clinical practice, this will help promote clinical nurses' mental health.

show abstract

The relationship between post‐traumatic stress and post‐traumatic growth in cancer patients and survivors: A systematic review and meta‐analysis

Cited by 124 publications

References 66 publications

Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic

Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic

Benefit finding in long-term prostate cancer survivors

The Traumatic Experience of Clinical Nurses During the COVID-19 Pandemic: Which Factors are Related to Post-Traumatic Growth?

Contact Info

Product

Resources

About